Davis Jerel is Director of Repare Therapeutics Inc.. Currently has a direct ownership of 25,131 shares of RPTX, which is worth approximately $33,172. The most recent transaction as insider was on Dec 29, 2022, when has been sold 4,254 shares (Common Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 25.1K
0% 3M change
0% 12M change
Total Value Held $33,172

Davis Jerel Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 29 2022
BUY
Other acquisition or disposition
-
4,254 Added 14.48%
25,131 Common Shares
Jun 06 2022
BUY
Other acquisition or disposition
-
9,101 Added 30.36%
20,877 Common Shares
Aug 05 2021
BUY
Other acquisition or disposition
-
19 Added 0.16%
11,776 Common Shares
Jun 01 2021
BUY
Other acquisition or disposition
-
9 Added 0.08%
11,757 Common Shares
May 05 2021
BUY
Other acquisition or disposition
-
2,842 Added 19.48%
11,748 Common Shares
Feb 16 2021
BUY
Other acquisition or disposition
-
830 Added 8.53%
8,906 Common Shares
Jan 29 2021
BUY
Other acquisition or disposition
-
5,277 Added 39.52%
8,076 Common Shares
Jan 14 2021
BUY
Other acquisition or disposition
-
2,799 Added 50.0%
2,799 Common Shares

Also insider at

KDNY
CHINOOK THERAPEUTICS, INC. Healthcare
GRPH
Graphite Bio, Inc. Healthcare
TSBX
Turnstone Biologics Corp.
DJ

Davis Jerel

Director
Seattle, WA

Track Institutional and Insider Activities on RPTX

Follow Repare Therapeutics Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RPTX shares.

Notify only if

Insider Trading

Get notified when an Repare Therapeutics Inc. insider buys or sells RPTX shares.

Notify only if

News

Receive news related to Repare Therapeutics Inc.

Track Activities on RPTX